Home
Clinical Trials
Study Evaluating Antibiotic U...

Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)

Last Updated: 2011-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

710 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-06-30

Study Completion Date

2005-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* To determine the value of using piperacillin/tazobactam in reducing the cases of ESBL producing E. coli or K. pneumoniae colonization and infection.
* To determine the acquisition rate of ESBL producing E. coli or K. pneumoniae, both pre and post intervention in the selected medical centers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Evaluation Tazocin Intervention

NCT00488189

Bacterial Infections

COMPLETED PHASE4

Tazocin Intervention Study

NCT00478855

Bacterial Infections

COMPLETED PHASE4

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

NCT00167999

Gram-Positive Bacterial Infections Escherichia Coli Infections Klebsiella Infections

COMPLETED

Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance

NCT01788449

Bacterial Infections

COMPLETED

Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

NCT00195286

Urinary Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacterial Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extended-Spectrum-Lactamases (ESBLs)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted or transferred to the ICU/pulmonary/hematology units.
* Patients of either sex, 18 years of age or older

Exclusion Criteria

* Pregnant and nursing women. Female of childbearing potential without using any birth control methods. Female of childbearing potential using oral contraceptives during study period. (Note: penicillin and beta-lactamase inhibitors may prevent oral contraceptives from working properly, increasing the chance of pregnancy).
* Patients who have the contraindications of using Tazocin (pipercillin/tazobactam)

Other exclusions apply.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers